A phase II open-label, single-centre, non-randomized trial of Y90 transarterial radioembolization in combination with nivolumab in Asian patients with intermediate stage hepatocellular carcinoma: An immunological study of radioembolization in combination with anti-PD1 therapy in HCC.

被引：6

作者：

Chang, Esther Wei Yin

Tai, David Wai-Meng

Koo, Si-Lin

Ng, Matthew C. H.

Yeong, Joe Poh Sheng

Zhai, Wei Wei

Newell, Evan

Chow, Pierce K. H.

Lim, Kiat Hon

Gogna, Apoorva

Tong, Aaron Kian Ti

Huang, Hian Liang

Loke, Kelvin Siu Hoong

Ng, David Chee Eng

Hennedige, Tiffany Priyanthi

Thng, Choon Hua

Choo, Su Pin

机构：

[1] Natl Canc Ctr, Singapore Hlth Serv, Singapore, Singapore

[2] Natl Canc Ctr Singapore, Singapore, Singapore

[3] Singapore Gen Hosp, Singapore, Singapore

[4] Genome Inst Singapore, Singapore, Singapore

[5] Singapore Immunol Network, Singapore, Singapore

来源：

关键词：

D O I：

10.1200/JCO.2018.36.4_suppl.TPS542

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS542

引用

页数：1